Clinical Trials List
2019-04-30 - 2024-12-31
Phase III
Recruiting5
ICD-9185
Malignant neoplasm of prostate
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Tzu-chun Wei Division of Urology
- 潘競成 Division of Others
- Yen-Hwa Chang Division of Urology
- 朱力行 Division of Nuclear Medicine
- Hsiao-Jen Chung Division of Urology
- 沈書慧 Division of Radiology
- Chien-Hsin Ting Division of Nuclear Medicine
- 陳威任 Division of Urology
- Tzu-Ping Lin Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- - - Division of Urology
- Ying-Chun Shen Division of Hematology & Oncology
- 王中傑 Division of Others
- YU-CHUAN LU Division of Urology
- YEN-HENG LIN Division of Radiology
- Yeong-Shiau Pu Division of Urology
- Yu-Chieh Tsai Division of Hematology & Oncology
- CHING-CHU LU Division of Nuclear Medicine
- PO-MING CHOW Division of Urology
- JHE-CYUAN GUO Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Huei Chang Division of Urology
- 陳冠亨 Division of Urology
- Po-Jen Hsiao Division of Urology
- Hsi-Chin Wu Division of Urology
- Che-Hung Lin Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
- 謝德鈞 Division of Nuclear Medicine
- Chi-Ping Huang Division of Urology
- Wei-Ching Lin Division of Radiology
- Chi-Rei Yang Division of Urology
- Su-Peng Yeh Division of Hematology & Oncology
- Han Chang Division of Others -
- Po-Fan Hsieh Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shian-Shiang Wang Division of Urology
- Chia-Yen Lin Division of Urology
- 蔡世傳 Division of Nuclear Medicine
- Cheng-Kuang Yang Division of Urology
- 王樹吉 Division of Urology
- Jian-Ri Li Division of Urology
- 裘坤元 Division of Urology
- 盧嘉文 Division of Urology
- 洪啟峰 Division of Urology
- Cheng-Che Chen Division of Urology
- 洪晟鈞 Division of Urology
- 熊小澐 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 劉展榮 Division of Urology
- Jiann-Hui Ou Division of Urology
- Jui-Hung Tsai Division of Hematology & Oncology
- Che-Yuan Hu Division of Urology
- Wu-Chou Su Division of Hematology & Oncology
- Yuh-Shyan Tsai Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25~35 participants
-
Global
780 participants